General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0YZEVV
ADC Name
MT-5111
Synonyms
MT 5111; MT-5111; MT5111
   Click to Show/Hide
Organization
Molecular Templates, Inc.
Drug Status
Phase 1 (Terminated)
Indication
In total 4 Indication(s)
Breast cancer
Phase 1
Clinical Trial
Gastric cancer
Phase 1
Clinical Trial
Oesophageal cancer
Phase 1
Clinical Trial
Solid tumor
Phase 1
Clinical Trial
Drug-to-Antibody Ratio
Undisclosed
Antibody Name
Undisclosed
Antigen Name
Receptor tyrosine-protein kinase erbB-2 (HER2)
 Antigen Info 
Payload Name
Shiga toxin B subunit (StxB)
 Payload Info 
Therapeutic Target
Ribosome (RB)
 Target Info 
Linker Name
Undisclosed
Conjugate Type
Undisclosed
DrugMap ID
DM5SN0A
TTD ID
DS60CK